Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kavita V. Nair
Natalizumab Versus Fingolimod and Dimethyl Fumarate in Multiple Sclerosis Treatment
Annals of Clinical and Translational Neurology
Neuroscience
Neurology
Factors Associated With Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)
Advances in Therapy
Medicine
Pharmacology
Related publications
Comparison of Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two-Year Experience
Multiple Sclerosis Journal – Experimental, Translational and Clinical
HDL-cholesterol Elevation Associated With Fingolimod and Dimethyl Fumarate Therapies in Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Dimethyl Fumarate Treatment Alters NK Cell Function in Multiple Sclerosis
European Journal of Immunology
Allergy
Immunology
Dimethyl Fumarate for Relapsingremitting Multiple Sclerosis
Prescriber
Pharmacology
Natalizumab Treatment in Multiple Sclerosis
Clinical Neurology
Neurology
Predictors for Multiple Sclerosis Relapses After Switching From Natalizumab to Fingolimod
Multiple Sclerosis
Neurology
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology
Tumefactive Multiple Sclerosis Lesions Under Fingolimod Treatment
Neurology
Neurology
Correction To: Switching From Natalizumab to Fingolimod Treatment in Multiple Sclerosis: Real Life Data From the Austrian MS Treatment Registry
Journal of Neurology
Neurology
